VHCP Management II’s 10x Genomics TXG Stock Holding History

VHCP Management II’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$136M	Hold	1,786,431	–	–	35.91%	1
2019 Q3	$90M	Buy	+1,786,431	New	+$98.9M	34.31%	1

Other funds holding TXG

FCMI

Foresite Capital Management I Larkspur, California $21.4M AUM 80.48% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JCM

JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VHCP Management II's TXG Position: Q4 2019 in Review

VHCP Management II held its 10x Genomics (TXG) position steady in Q4 2019 at 1,786,431 shares worth $136M. The position accounts for 35.91% of the portfolio, ranked #1.

VHCP Management II first reported a position in TXG in Q3 2019 and has held it in 2 quarters since. 85 funds tracked by Wall St. Rank hold TXG as of Q4 2019.

VHCP Management II held 1,786,431 shares of 10x Genomics worth $136M as of Q4 2019.
VHCP Management II left its 10x Genomics share count unchanged in Q4 2019.
10x Genomics made up 35.91% of VHCP Management II's portfolio in Q4 2019, its #1 holding.
VHCP Management II first reported a position in 10x Genomics in Q3 2019 and has held it in 2 quarters since.
85 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2019.

Based on VHCP Management II's 13F filing for Q4 2019, filed 13 Feb 2020.